This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Value Line Investment Survey Initiates Coverage Of Mindray Medical International And Ultratech, Inc.

Value Line (NASDAQ: VALU) has initiated coverage of Mindray Medical and Ultratech, Inc. in its flagship product, The Value Line Investment Survey ®. Beginning Monday, August 20 th, Value Line’s analysts are evaluating the performance and business fundamentals of these stocks. The following is based on recent SEC filing information.

Mindray Medical International is a developer, manufacturer, and marketer of a broad range of medical devices across three primary business segments: patient monitoring & life-support products; in-vitro diagnostic products; and medical imaging systems. In 2011, it recorded revenues of more than $880 million, and the stock’s market capitalization exceeds $4.0 billion. The company is headquartered in Nanshan, Shenzhen, China.

Ultratech, Inc. engages in the development, production, and marketing of photolithography and laser thermal processing equipment. It currently offers two different systems for use in the semiconductor fabrication process, and markets its products and services to semiconductor and nanotechnology device manufacturers; 2011 annual sales exceeded $200 million. The company is based in San Jose, California.

For more information about the particular investment merits of Mindray and Ultratech, subscribers can peruse our full-page research reports in The Value Line Investment Survey.

The Value Line Investment Survey, Value Line’s signature publication, is one of the most highly regarded and widely used independent investment research resources. Published weekly, it tracks approximately 1,700 stocks in over 90 industries and ranks those stocks on Timeliness™ and Safety™. It is available both online and in print.

Value Line, Inc. is a New York corporation headquartered in New York City and formed in 1982. The Company’s primary business is producing investment periodicals and related publications in both print and digital format and making available copyright data, including the proprietary Value Line Ranking System. The investment periodicals and related publications offered by Value Line Publishing LLC cover a broad spectrum of investments including stocks, mutual funds, options and convertible securities. The Company’s periodicals and related publications and services are of interest to individual and professional investors, as well as to institutions including municipal and university libraries and investment firms.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs